Chris Mullin, MS
Chris Mullin brings more than 15 years of experience in clinical trial design and biostatistics to advise clients on regulatory strategy and best practices for clear scientific communication. His specialty is translating complex ideas into easy-to-understand concepts. Chris honed his skills through diverse experiences in academia as a graduate instructor, and as a consultant for more than 100 start ups and large companies. He has designed and analyzed dozens of clinical trials, including large pivotal trials for ground-breaking technologies. Chris has also served in management roles with responsibilities for experts in biostatistics, biocompatability, quality systems, and regulatory affairs. He has experience in a variety of therapeutic areas, ranging from cardiovascular disease and neurology to infectious disease and emergency care. Chris has published more than 50 peer-reviewed articles, abstracts, and scientific posters, authored a book chapter on study design for translational research, developed and trained FDA review staff, and presented at numerous FDA Advisory Committee meetings.